The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...

Kevin McAllister is the new executive director at Face to Face, a Santa Rosa-based organization focused on ending HIV and ...

RANCHI: In a shocking case of negligence, a seven-year-old child, suffering from Thalassemia, reportedly contracted with HIV ...

Last month, the UK Government published its long-awaited 10-Year Health Plan, with one of its three key shifts being the move ...

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the ...

For couples, group sexual encounters present some unique sexual health challenges. Learn how relationship partners can meet ...

Men with HIV and severe sleep-disordered breathing experience the greatest sleep disruption, with lower efficiency, more light sleep, and unstable sleep stages.

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV ...

Gilead Sciences approaches Q3 2025 results on October 30, hitting new highs and presenting Livdelzi data at The Liver Meeting ...